Public Interest in the Off-Label Use of Glucagon-like Peptide 1 Agonists (Ozempic) for Cosmetic Weight Loss: A Google Trends Analysis

Sabrina H. Han, Rachel H. Safeek, Kyle M. Ockerman, Nhan Trieu, Patricia Mars, Audrey Klenke, Heather J. Furnas, Sarah C. Sorice-Virk

View at source ↗PDF ↗Article209 citations
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.

Record

Archive ID
doi:10.1093/asj/sjad211
Published
Jul 2, 2023
Venue
Aesthetic Surgery Journal
DOI
10.1093/asj/sjad211
PubMed
37402640
Categories
Pharmacology and Obesity Treatment
Provenance
openalex

Topics